Cravatex Limited Reports Mixed Q1 Results: Standalone Profit Amidst Consolidated Loss

1 min read     Updated on 12 Aug 2025, 07:04 PM
scanx
Reviewed by
Ashish TScanX News Team
Overview

Cravatex Limited announced its Q1 financial results, showing a mixed performance. Standalone operations were profitable with revenue of Rs. 144.14 lakhs and a profit of Rs. 44.21 lakhs. However, consolidated results showed a loss of Rs. 136.77 lakhs on revenue of Rs. 2,312.69 lakhs. The company's subsidiaries, BB (UK) Limited and BB Euro GmbH, contributed Rs. 2,554.16 lakhs in total income but reported a combined net loss of Rs. 180.99 lakhs. The standalone EPS was Rs. 1.71, while the consolidated EPS was negative at Rs. 5.29.

16551288

*this image is generated using AI for illustrative purposes only.

Cravatex Limited , a diversified company, has announced its unaudited financial results for the first quarter, revealing a mixed performance across its standalone and consolidated operations.

Standalone Performance

On a standalone basis, Cravatex Limited demonstrated a positive financial outcome for Q1:

  • Revenue from operations stood at Rs. 144.14 lakhs
  • Total income reached Rs. 279.48 lakhs
  • The company reported a profit of Rs. 44.21 lakhs
  • Basic earnings per share (EPS) was Rs. 1.71

Consolidated Results

The consolidated financial picture, however, presented some challenges:

  • Consolidated revenue from operations was Rs. 2,312.69 lakhs
  • Total income amounted to Rs. 2,833.65 lakhs
  • The group recorded a net loss of Rs. 136.77 lakhs

Subsidiary Performance

The consolidated results include the performance of Cravatex's subsidiaries:

  • BB (UK) Limited and BB Euro GmbH contributed a total income of Rs. 2,554.16 lakhs
  • These subsidiaries reported a combined net loss of Rs. 180.99 lakhs

Financial Highlights

Particulars (Rs. in lakhs) Standalone Q1 Consolidated Q1
Revenue from Operations 144.14 2,312.69
Total Income 279.48 2,833.65
Profit/(Loss) 44.21 (136.77)
EPS (Rs.) 1.71 (5.29)

Management Commentary

Rajesh Batra, Chairman and Managing Director of Cravatex Limited, approved the financial results along with the Board of Directors. The company's management and auditors have conducted a thorough review of both standalone and consolidated results.

Audit Review

GPS & Associates, the statutory auditors, have carried out a limited review of the financial results for the quarter, in accordance with the regulatory requirements.

Segment Information

Cravatex Limited continues to operate in a single primary business segment, as noted in the financial statement.

The financial results were reviewed by the Audit Committee and approved by the Board of Directors. The company has prepared the statement in accordance with the Indian Accounting Standards (Ind AS) prescribed under Section 133 of the Companies Act, 2013, and other recognized accounting practices and policies.

Investors and stakeholders should note that while the standalone entity has shown profitability, the consolidated results reflect the challenges faced by the group's international operations.

Historical Stock Returns for Cravatex

1 Day5 Days1 Month6 Months1 Year5 Years
-5.59%-4.18%-2.59%-18.27%-17.93%+27.87%
like17
dislike
Explore Other Articles
364.10
-21.55
(-5.59%)